Bionaturis Group growth, in the MedCap Forum

Bionaturis Group takes part one more year in the Small and Medium-Size Companies Forum -MedCap-, on May 31st and June 1st in Madrid.

Bionaturis Group CEO, Victor Infante, is the person in charge of presenting the latest milestones achieved by the company, among with we can highlight the establishment of the subsidiary BNT China Biosciences in China, the signing of a contract with the US National Institute of Environmental Health (NIEHS) and the recent acquisition of the company ZIP Solutions, that has signed a co-development and exclusive license agreement with a leading multinational company for the final development and market of Splittera® technology.

Thanks to these latest operations, Bionaturis Group continues positioning as a reference company in its area, through its four companies and two subsidiaries with presence in Europe, USA and Asia. The Group offers premium services and products for human and animal health.

In this edition of the MedCap Forum, Bionaturis Group takes part in both ‘One to One’ meetings and the Discovery Meeting, with a lecturer in the afternoon on May, 31st, available here.

About the MedCap

The 11nd MEDCAP Forum gathers the main Small and Medium Size Companies listed on the Spanish Stock Exchange Market as well as institutional investors, brokers and financial analysts. The program includes both sectorial and general round tables, as well as the possibility of holding ‘One to One’ meetings. The main goal of the event is to stimulate the liquidity and founding of these companies.

About Bionaturis Group

Bionaturis Group offers cutting-edge biotechnological drugs and services for human and animal health. Considered an international benchmark in vaccines research, the biotechnological Group which envisions a global access to health is listed on the Spanish stock exchange for SMEs (ticker BNT). In addition to this […]

May 31st, 2016|Blog english, congress, Hechos Relevantes|Comments Off|

Bionaturis turns two years on the MAB: 3, 2, 1… ready to take off!

It is just two years ago that Bionaturis started quoting on the Spanish Alternative Stock Market (MAB). On 26th January, 2012; the managers of the company began the new age ringing the bell at the opening session of its quotation. Since then, Bionaturis has had an exponential growth and the future prospects can’t be better, as our general manager, Javier Gallastegui, states.

-How do you remember the IPO process and Bionaturis’ opening day at MAB?

-My arrival at the company was in a key moment because I started to work at Bionaturis very little time before trading at the MAB, so, the process was already ongoing. About that day, I remember moments of great happiness, with emotion and pride shared with our team, which was there all together. We realized how well-known people both in the industry and the financial sector, among them my closest guests, looked with admiration at such an important milestone we were achieving.  Among them Emilio Moraleda, who joined our Board of Directors shortly after that.

-What has the MAB provided to Bionaturis’ development these two years?

-Apart from the logical contribution as source of capital income, for our development and current position being a transparent trading company for the lens of our multinational customers, our investors and the stock market is very important. The experience and the balance, according to facts and results, can’t be more positive: the company market cap has more than doubled since then and so our multinational clients and product portfolio as well. The future is bright ahead of us.

-How do you describe the current situation of Bionaturis on the MAB?

-With a great strength, and as it’s usual to say in these cases, I am not the person who […]

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.